{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-068701","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.592692+00:00","generated_at":"2026-06-01T06:14:19.630815+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Annovis Bio schedules investor webcast for June 11 to discuss Buntanetap progress","bullets":["Webcast scheduled for June 11, 2024 at 4:30pm ET; registration via Zoom link provided.","Topics include recent Buntanetap developments, upcoming clinical trial plans, and company progress.","Buntanetap is a late-stage drug candidate for Alzheimer's and Parkinson's diseases.","No specific data or results disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-068701","json":"https://secwatch.observer/filing/0001104659-24-068701.json","markdown":"https://secwatch.observer/filing/0001104659-24-068701.md","text":"https://secwatch.observer/filing/0001104659-24-068701.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924068701/0001104659-24-068701-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924068701/tm2416510d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:14:19.630815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}